Masato Satoh
Ferring Pharmaceuticals
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Masato Satoh.
Bioorganic & Medicinal Chemistry Letters | 1996
Graeme Semple; Hamish Ryder; David A. Kendrick; Michael Szelke; Mitsuaki Ohta; Masato Satoh; Akito Nishida; Shinobu Akuzawa; Keiji Miyata
Abstract A novel series of 1-alkylcarbonylmethyl analogues of the potent gastrin/CCK-B receptor antagonist YM022 have been prepared. A number of analogues retained good affinity for the gastrin/CCK-B receptor and one compound (6d) showed improved binding and enhanced selectivity for this receptor over CCK-A. A second compound (6j) gave improved in vivo inhibition of gastric acid secretion in rats. Both analogues were shown to have significantly better activity in the same model following i.d. dosing than either YM022 or L-365,260.
Bioorganic & Medicinal Chemistry Letters | 1996
Graeme Semple; Hamish Ryder; David A. Kendrick; Michael Szelke; Mitsuaki Ohta; Masato Satoh; Akito Nishida; Shinobu Akuzawa; Keiji Miyata
Abstract A novel series of analogues of the potent gastrin/CCK-B receptor antagonist YM022 have been prepared which incorporate 5- and 6-membered heteroaromatic rings in the benzodiazepine 5-position. The 5-(2-pyridyl) derivatives in particular retained good in vitro and in vivo potency and one such compound 9i was shown to inhibit acid secretion after oral dosing in dogs. Improved bioavailability for 9i over the 5-phenyl analogue, 9h was demonstrated in rats.
Synthetic Communications | 1996
Graeme Semple; Hamish Ryder; Mitsuaki Ohta; Masato Satoh
Abstract A facile method for the synthesis of 3-amino-5-(2-pyridyl)-1,4-benzodiazepin-2-ones (8) mediated by benzotriazole is described. The synthesis and optical resolution of the product by fractional crystallisation proceeds in high yield, under mild conditions and without recourse to toxic reagents or chromatographic separations and hence is amenable to the large scale preparation of these important precursors to potent CCK receptor ligands.
Journal of Medicinal Chemistry | 1997
Graeme Semple; Hamish Ryder; David Philip Rooker; Andrzej Roman Batt; David A. Kendrick; Michael Szelke; Mitsuaki Ohta; Masato Satoh; Akito Nishida; Shinobu Akuzawa; Keiji Miyata
Chemical & Pharmaceutical Bulletin | 1995
Masato Satoh; Yutaka Kondoh; Yoshinori Okamoto; Akito Nishida; Keiji Miyata; Mitsuaki Ohta; Toshiyasu Mase; Kiyoshi Murase
Archive | 1993
Hamish Ryder; Graeme Semple; David A. Kendrick; Michael Szelke; Masato Satoh; Mitsuaki Ohta; Keiji Miyata; Akito Nishida
Archive | 1994
Graeme Semple; Hamish Ryder; Michael Szelke; Masato Satoh; Mitsuaki Ohta; Keiji Miyata; Akito Nishida; Masato Ishii
Archive | 1994
Graeme Semple; Hamish Ryder; Michael Szelke; Masato Satoh; Mitsuaki Ohta; Keiji Miyata; Akito Nishida; Masato Ishii
Archive | 1996
Masato Satoh; Yutaka Kondoh; Yoshinori Okamoto; Akito Nishida; Kazuo Honda; Masayuki Saito
Chemical & Pharmaceutical Bulletin | 1996
Masato Satoh; Yoshinori Okamoto; Hiroyuki Koshio; Mitsuaki Ohta; Akito Nishida; Shinobu Akuzawa; Keiji Miyata; Toshiyasu Mase; Graeme Semple